{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:24Z","timestamp":1792783104346,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C16\/18\/007"],"award-info":[{"award-number":["C16\/18\/007"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/20\/117, DOAC14\/19\/092, IDN\/20\/019"],"award-info":[{"award-number":["C14\/20\/117, DOAC14\/19\/092, IDN\/20\/019"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FWO","award":["G0E8420N"],"award-info":[{"award-number":["G0E8420N"]}]},{"name":"FWO","award":["18B2122N"],"award-info":[{"award-number":["18B2122N"]}]},{"name":"FWO","award":["G099922N and G0B2120N"],"award-info":[{"award-number":["G099922N and G0B2120N"]}]},{"name":"FWO","award":["G054022"],"award-info":[{"award-number":["G054022"]}]},{"name":"FWO","award":["11E0123N"],"award-info":[{"award-number":["11E0123N"]}]},{"name":"FWO","award":["1805518N"],"award-info":[{"award-number":["1805518N"]}]},{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["948959"],"award-info":[{"award-number":["948959"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["grant Hippocrates"],"award-info":[{"award-number":["grant Hippocrates"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Flemish Institute of Biotechnology","award":["Grand Challenges project Spartacus"],"award-info":[{"award-number":["Grand Challenges project Spartacus"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Deficiency of human adenosine deaminase type 2 (DADA2) is a complex systemic autoinflammatory disorder characterized by vasculopathy, immune dysregulation, and hematologic abnormalities. The most notable neurological manifestations of DADA2 are strokes that can manifest with various neurological symptoms and are potentially fatal. However, neurological presentations can be diverse. We here present a review of the neurological manifestations of DADA2 to increase clinical awareness of DADA2 as the underlying diagnosis. We reviewed all published cases of DADA2 from 1 January 2014 until 19 July 2022 found via PubMed. A total of 129 articles describing the clinical features of DADA2 were included in the analysis. Six hundred twenty-eight patients diagnosed with DADA2 were included in the review. 50.3% of patients had at least signs of one reported neurological event, which was the initial or sole manifestation in 5.7% and 0.6%, respectively. 77.5% of patients with neurological manifestations had at least signs of one cerebrovascular accident, with lacunar strokes being the most common and 35.9% of them having multiple stroke episodes. There is a remarkable predilection for the brain stem and deep gray matter, with 37.3% and 41.6% of ischemic strokes, respectively. Other neurological involvement included neuropathies, focal neurological deficits, ophthalmological findings, convulsions, and headaches. In summary, neurological manifestations affect a significant proportion of patients with DADA2, and the phenotype is broad. Neurological manifestations can be the first and single manifestation of DADA2. Therefore, stroke, encephalitis, posterior reversible encephalopathy syndrome, mononeuropathy and polyneuropathy, and Beh\u00e7et\u2019s disease-like presentations should prompt the neurologist to exclude DADA2, especially but not only in childhood.<\/jats:p>","DOI":"10.1007\/s10875-023-01555-y","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T01:01:53Z","timestamp":1691370113000},"page":"1916-1926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2077-4295","authenticated-orcid":false,"given":"Mariia","family":"Dzhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-001X","authenticated-orcid":false,"given":"Lisa","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4261-6220","authenticated-orcid":false,"given":"Rik","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8488-5090","authenticated-orcid":false,"given":"Lien","family":"De Somer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4003-5465","authenticated-orcid":false,"given":"Steven","family":"Vanderschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6708-9925","authenticated-orcid":false,"given":"Marco","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Moens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Verhaaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-3092","authenticated-orcid":false,"given":"Rik","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-0738","authenticated-orcid":false,"given":"Giorgia","family":"Bucciol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-0302","authenticated-orcid":false,"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"issue":"10","key":"1555_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1307361.","journal-title":"N Engl J Med."},{"issue":"10","key":"1555_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1307362.","journal-title":"N Engl J Med."},{"issue":"11","key":"1555_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-017-0699-8","volume":"19","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kelly SJ, Ganson NJ, Hershfield MS. Deficiency of adenosine deaminase 2 (DADA2), an inherited cause of polyarteritis nodosa and a mimic of other systemic rheumatologic disorders. Curr Rheumatol Rep. 2017;19(11):70. https:\/\/doi.org\/10.1007\/s11926-017-0699-8.","journal-title":"Curr Rheumatol Rep."},{"issue":"5","key":"1555_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38(5):569\u201378. https:\/\/doi.org\/10.1007\/s10875-018-0525-8.","journal-title":"J Clin Immunol."},{"key":"1555_CR5","doi-asserted-by":"publisher","first-page":"935957","DOI":"10.3389\/fimmu.2022.935957","volume":"13","author":"S Signa","year":"2022","unstructured":"Signa S, Bertoni A, Penco F, et al. Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity. Front Immunol. 2022;13:935957. https:\/\/doi.org\/10.3389\/fimmu.2022.935957.","journal-title":"Front Immunol."},{"key":"1555_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fped.2018.00282","volume":"6","author":"PY Lee","year":"2018","unstructured":"Lee PY. Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2. Front Pediatr. 2018;6:282. https:\/\/doi.org\/10.3389\/fped.2018.00282.","journal-title":"Front Pediatr."},{"issue":"10277","key":"1555_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(20)32660-X","volume":"397","author":"G Bourgeois","year":"2021","unstructured":"Bourgeois G, Richard M, Danset M, P\u00e9rard L, Breton AL, Berthoux E. Deficiency of adenosine deaminase 2 diagnosed at 65 years of age. Lancet Lond Engl. 2021;397(10277):913. https:\/\/doi.org\/10.1016\/S0140-6736(20)32660-X.","journal-title":"Lancet Lond Engl."},{"issue":"4","key":"1555_CR8","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141(4):1534\u20131537.e8. https:\/\/doi.org\/10.1016\/j.jaci.2018.01.012.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"1555_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/art.41500","volume":"73","author":"A Sharma","year":"2021","unstructured":"Sharma A, Naidu G, Sharma V, et al. Deficiency of adenosine deaminase 2 in adults and children: experience from India. Arthritis Rheumatol Hoboken NJ. 2021;73(2):276\u201385. https:\/\/doi.org\/10.1002\/art.41500.","journal-title":"Arthritis Rheumatol Hoboken NJ."},{"issue":"10","key":"1555_CR10","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648\u201356. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210802.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"1555_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/art.41549","volume":"73","author":"O Schnappauf","year":"2021","unstructured":"Schnappauf O, Sampaio Moura N, Aksentijevich I, et al. Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2. Arthritis Rheumatol. 2021;73(3):512\u20139. https:\/\/doi.org\/10.1002\/art.41549.","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"1555_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jaci.2021.04.034","volume":"149","author":"H Jee","year":"2022","unstructured":"Jee H, Huang Z, Baxter S, et al. Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. J Allergy Clin Immunol. 2022;149(1):379\u201387. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.034.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"1555_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2021.01.018","volume":"148","author":"H Nihira","year":"2021","unstructured":"Nihira H, Izawa K, Ito M, et al. Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation. J Allergy Clin Immunol. 2021;148(2):550\u201362. https:\/\/doi.org\/10.1016\/j.jaci.2021.01.018.","journal-title":"J Allergy Clin Immunol."},{"key":"1555_CR14","doi-asserted-by":"publisher","first-page":"811473","DOI":"10.3389\/fimmu.2021.811473","volume":"12","author":"KS Barron","year":"2021","unstructured":"Barron KS, Aksentijevich I, Deuitch NT, et al. The spectrum of the deficiency of adenosine deaminase 2: an observational analysis of a 60 patient cohort. Front Immunol. 2021;12:811473. https:\/\/doi.org\/10.3389\/fimmu.2021.811473.","journal-title":"Front Immunol."},{"issue":"2","key":"1555_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279\u201390. https:\/\/doi.org\/10.1189\/jlb.1109764.","journal-title":"J Leukoc Biol."},{"issue":"1","key":"1555_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1546-0096-12-44","volume":"12","author":"A Belot","year":"2014","unstructured":"Belot A, Wassmer E, Twilt M, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol. 2014;12(1):44. https:\/\/doi.org\/10.1186\/1546-0096-12-44.","journal-title":"Pediatr Rheumatol."},{"issue":"4","key":"1555_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood.2018892752","volume":"134","author":"C Carmona-Rivera","year":"2019","unstructured":"Carmona-Rivera C, Khaznadar SS, Shwin KW, et al. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood. 2019;134(4):395\u2013406. https:\/\/doi.org\/10.1182\/blood.2018892752.","journal-title":"Blood."},{"issue":"1","key":"1555_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12969-019-0334-5","volume":"17","author":"K Clarke","year":"2019","unstructured":"Clarke K, Campbell C, Omoyinmi E, et al. Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2). Pediatr Rheumatol. 2019;17(1):39. https:\/\/doi.org\/10.1186\/s12969-019-0334-5.","journal-title":"Pediatr Rheumatol."},{"issue":"3","key":"1555_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.semarthrit.2021.04.009","volume":"51","author":"M Kasap Cuceoglu","year":"2021","unstructured":"Kasap Cuceoglu M, Sener S, Batu ED, et al. Systematic review of childhood-onset polyarteritis nodosa and DADA2. Semin Arthritis Rheum. 2021;51(3):559\u201364. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.009.","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"1555_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3899\/jrheum.181384","volume":"47","author":"S \u00d6zen","year":"2020","unstructured":"\u00d6zen S, Batu ED, Ta\u015fk\u0131ran EZ, et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2. J Rheumatol. 2020;47(1):117\u201325. https:\/\/doi.org\/10.3899\/jrheum.181384.","journal-title":"J Rheumatol."},{"issue":"20","key":"1555_CR21","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000001581","volume":"84","author":"WF Westendorp","year":"2015","unstructured":"Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KPJ. Unexplained early-onset lacunar stroke and inflammatory skin lesions: consider ADA2 deficiency. Neurology. 2015;84(20):2092\u20133. https:\/\/doi.org\/10.1212\/WNL.0000000000001581.","journal-title":"Neurology."},{"key":"1555_CR22","doi-asserted-by":"publisher","unstructured":"Varghese A, Thomas J, Maramattom B. \u2018More than just skin in the game\u2019. DADA2 autoinflammatory syndrome and stroke in the young. Ann Indian Acad Neurol. 2021;24(3):410 https:\/\/doi.org\/10.4103\/aian.AIAN_716_20.","DOI":"10.4103\/aian.AIAN_716_20"},{"issue":"02","key":"1555_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0036-1597611","volume":"48","author":"M Elbracht","year":"2016","unstructured":"Elbracht M, Mull M, Wagner N, et al. Stroke as initial manifestation of adenosine deaminase 2 deficiency. Neuropediatrics. 2016;48(02):111\u20134. https:\/\/doi.org\/10.1055\/s-0036-1597611.","journal-title":"Neuropediatrics."},{"issue":"06","key":"1555_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1055\/a-1896-5817","volume":"53","author":"J Gburek-Augustat","year":"2022","unstructured":"Gburek-Augustat J, Platzer K, Schumann I, et al. Case report: Deficiency of adenosine deaminase 2 (DADA2) as a cause of brainstem stroke in a 3-year-old girl and the importance of early fast-track genetic diagnostics to influence therapy. Neuropediatrics. 2022;53(06):432\u20135. https:\/\/doi.org\/10.1055\/a-1896-5817.","journal-title":"Neuropediatrics."},{"issue":"6","key":"1555_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.semarthrit.2021.09.001","volume":"51","author":"A Fayand","year":"2021","unstructured":"Fayand A, Chasset F, Boutboul D, et al. DADA2 diagnosed in adulthood versus childhood: a comparative study on 306 patients including a systematic literature review and 12 French cases. Semin Arthritis Rheum. 2021;51(6):1170\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.09.001.","journal-title":"Semin Arthritis Rheum."},{"issue":"5","key":"1555_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1056\/NEJMc1405506","volume":"371","author":"DL Kastner","year":"2014","unstructured":"Kastner DL, Zhou Q, Aksentijevich I. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):480\u20131. https:\/\/doi.org\/10.1056\/NEJMc1405506.","journal-title":"N Engl J Med."},{"issue":"5","key":"1555_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJMc1405506","volume":"371","author":"R Segel","year":"2014","unstructured":"Segel R, King MC, Levy-Lahad E. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):481. https:\/\/doi.org\/10.1056\/NEJMc1405506.","journal-title":"N Engl J Med."},{"issue":"1","key":"1555_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-genom-090413-025334","volume":"17","author":"M Stoffels","year":"2016","unstructured":"Stoffels M, Kastner DL. Old dogs, new tricks: monogenic autoinflammatory disease unleashed. Annu Rev Genomics Hum Genet. 2016;17(1):245\u201372. https:\/\/doi.org\/10.1146\/annurev-genom-090413-025334.","journal-title":"Annu Rev Genomics Hum Genet."},{"issue":"10","key":"1555_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00296-018-4122-1","volume":"38","author":"O Karadag","year":"2018","unstructured":"Karadag O, Erden A, Bilginer Y, et al. A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts. Rheumatol Int. 2018;38(10):1833\u201340. https:\/\/doi.org\/10.1007\/s00296-018-4122-1.","journal-title":"Rheumatol Int."},{"issue":"11","key":"1555_CR30","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41431-018-0240-1","volume":"26","author":"HE S\u00f6nmez","year":"2018","unstructured":"S\u00f6nmez HE, Batu ED, Ta\u015fk\u0131ran EZ, Alika\u015fifo\u011flu M, Bilginer Y, \u00d6zen S. Genetic testing for DADA2: how can we avoid missing patients? Eur J Hum Genet. 2018;26(11):1563\u20135. https:\/\/doi.org\/10.1038\/s41431-018-0240-1.","journal-title":"Eur J Hum Genet."},{"issue":"5-6","key":"1555_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000495794","volume":"46","author":"GC Santo","year":"2018","unstructured":"Santo GC, Baldeiras I, Guerreiro R, et al. Adenosine deaminase two and immunoglobulin M accurately differentiate adult Sneddon\u2019s syndrome of unknown cause. Cerebrovasc Dis. 2018;46(5-6):257\u201364. https:\/\/doi.org\/10.1159\/000495794.","journal-title":"Cerebrovasc Dis."},{"issue":"4","key":"1555_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood.2019001251","volume":"134","author":"PY Lee","year":"2019","unstructured":"Lee PY. NETing the mechanism of inflammation in DADA2. Blood. 2019;134(4):338\u20139. https:\/\/doi.org\/10.1182\/blood.2019001251.","journal-title":"Blood."},{"key":"1555_CR33","doi-asserted-by":"publisher","unstructured":"Zervou M, Goulielmos G, Matalliotakis M, Matalliotaki C, Spandidos D, Eliopoulos E. Role of adenosine deaminase 2 gene variants in pediatric deficiency of adenosine deaminase 2: a structural biological approach. Mol Med Rep. Published online December. 2019;5 https:\/\/doi.org\/10.3892\/mmr.2019.10862.","DOI":"10.3892\/mmr.2019.10862"},{"issue":"1","key":"1555_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-020-0417-3","volume":"18","author":"A Baytaro\u011flu","year":"2020","unstructured":"Baytaro\u011flu A, Kadayif\u00e7ilar S, A\u011fin A, et al. Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency. Pediatr Rheumatol. 2020;18(1):29. https:\/\/doi.org\/10.1186\/s12969-020-0417-3.","journal-title":"Pediatr Rheumatol."},{"issue":"6","key":"1555_CR35","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.jaci.2020.04.023","volume":"145","author":"O Schnappauf","year":"2020","unstructured":"Schnappauf O, Ombrello AK, Kastner DL. Deficiency of adenosine deaminase 2: is it an elephant after all? J Allergy Clin Immunol. 2020;145(6):1560\u20131. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.023.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"1555_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/JLB.3CE1021-561R","volume":"111","author":"C Mesa-Nu\u00f1ez","year":"2022","unstructured":"Mesa-Nu\u00f1ez C, Mortellaro A. T cells and monocytes: a dangerous liaison in adenosine deaminase 2 deficiency. J Leukoc Biol. 2022;111(2):297\u20139. https:\/\/doi.org\/10.1002\/JLB.3CE1021-561R.","journal-title":"J Leukoc Biol."},{"issue":"11","key":"1555_CR37","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1097\/HS9.0000000000000653","volume":"5","author":"F Vinchi","year":"2021","unstructured":"Vinchi F. Towards a cure for adenosine deaminase 2 deficiency through genetic correction of macrophage polarization. HemaSphere. 2021;5(11):e653. https:\/\/doi.org\/10.1097\/HS9.0000000000000653.","journal-title":"HemaSphere."},{"issue":"2","key":"1555_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.5A0621-314R","volume":"111","author":"Z Wu","year":"2022","unstructured":"Wu Z, Gao S, Watanabe N, et al. Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2. J Leukoc Biol. 2022;111(2):301\u201312. https:\/\/doi.org\/10.1002\/JLB.5A0621-314R.","journal-title":"J Leukoc Biol."},{"issue":"18","key":"1555_CR39","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.3390\/molecules26185707","volume":"26","author":"A Cafaro","year":"2021","unstructured":"Cafaro A, Pigliasco F, Barco S, et al. A novel LC\u2013MS\/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot. Molecules. 2021;26(18):5707. https:\/\/doi.org\/10.3390\/molecules26185707.","journal-title":"Molecules."},{"issue":"7","key":"1555_CR40","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10875-021-01121-4","volume":"41","author":"M Yamashita","year":"2021","unstructured":"Yamashita M, Morio T. Another exciting data\u2014HCT successfully cured patients with DADA2: a commentary on \u201cHematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients\u201d by Hashem H et al. J Clin Immunol. 2021;41(7):1443\u20135. https:\/\/doi.org\/10.1007\/s10875-021-01121-4.","journal-title":"J Clin Immunol."},{"key":"1555_CR41","doi-asserted-by":"publisher","first-page":"114292","DOI":"10.1016\/j.ab.2021.114292","volume":"628","author":"M Ito","year":"2021","unstructured":"Ito M, Nihira H, Izawa K, Yasumi T, Nishikomori R, Iwaki-Egawa S. Enzyme activity in dried blood spot as a diagnostic tool for adenosine deaminase 2 deficiency. Anal Biochem. 2021;628:114292. https:\/\/doi.org\/10.1016\/j.ab.2021.114292.","journal-title":"Anal Biochem."},{"issue":"4","key":"1555_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.semarthrit.2021.04.013","volume":"51","author":"U Kaya Akca","year":"2021","unstructured":"Kaya Akca U, Sag E, Unal S, Kasap Cuceoglu M, Bilginer Y, Ozen S. The role of vascular inflammation markers in deficiency of adenosine deaminase 2. Semin Arthritis Rheum. 2021;51(4):839\u201344. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.013.","journal-title":"Semin Arthritis Rheum."},{"issue":"3","key":"1555_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/JLB.5CE0421-186R","volume":"110","author":"L Ehlers","year":"2021","unstructured":"Ehlers L, Meyts I. What a difference ADA2 makes: insights into the pathophysiology of ADA2 deficiency from single-cell RNA sequencing of monocytes. J Leukoc Biol. 2021;110(3):405\u20137. https:\/\/doi.org\/10.1002\/JLB.5CE0421-186R.","journal-title":"J Leukoc Biol."},{"issue":"1","key":"1555_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3892\/mmr.2021.12128","volume":"24","author":"M Zervou","year":"2021","unstructured":"Zervou M, Goulielmos G, Matalliotakis M, Matalliotaki C, Spandidos D, Eliopoulos E. [Corrigendum] Role of adenosine deaminase 2 gene variants in pediatric deficiency of adenosine deaminase 2: a structural biological approach. Mol Med Rep. 2021;24(1):489. https:\/\/doi.org\/10.3892\/mmr.2021.12128.","journal-title":"Mol Med Rep."},{"issue":"9","key":"1555_CR45","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00296-021-04867-7","volume":"41","author":"G Naidu","year":"2021","unstructured":"Naidu G, Kopp CR, Sharma V, et al. Validation of the provisional seven-item criteria for the diagnosis of polyarteritis nodosa. Rheumatol Int. 2021;41(9):1651\u20135. https:\/\/doi.org\/10.1007\/s00296-021-04867-7.","journal-title":"Rheumatol Int."},{"issue":"6","key":"1555_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/annrheumdis-2020-219137","volume":"80","author":"DM Schwartz","year":"2021","unstructured":"Schwartz DM, Kitakule MM, Dizon BL, et al. Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features. Ann Rheum Dis. 2021;80(6):788\u201395. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219137.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"1555_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/eji.202048549","volume":"51","author":"F Schena","year":"2021","unstructured":"Schena F, Penco F, Volpi S, et al. Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients. Eur J Immunol. 2021;51(1):206\u201319. https:\/\/doi.org\/10.1002\/eji.202048549.","journal-title":"Eur J Immunol."},{"issue":"1","key":"1555_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","volume":"14","author":"R Caorsi","year":"2016","unstructured":"Caorsi R, Penco F, Schena F, Gattorno M. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatr Rheumatol. 2016;14(1):51. https:\/\/doi.org\/10.1186\/s12969-016-0111-7.","journal-title":"Pediatr Rheumatol."},{"issue":"7","key":"1555_CR49","first-page":"435","volume":"19","author":"Y Berkun","year":"2017","unstructured":"Berkun Y, Segel R, Navon-Elkan P. Adenosine deaminase 2 deficiency: more than monogenic vasculitis. Isr Med Assoc J IMAJ. 2017;19(7):435\u20137.","journal-title":"Isr Med Assoc J IMAJ."},{"issue":"1","key":"1555_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00296-017-3839-6","volume":"38","author":"A Jain","year":"2018","unstructured":"Jain A, Misra DP, Sharma A, Wakhlu A, Agarwal V, Negi VS. Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes. Rheumatol Int. 2018;38(1):13\u201324. https:\/\/doi.org\/10.1007\/s00296-017-3839-6.","journal-title":"Rheumatol Int."},{"key":"1555_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/1756-185X.13283","volume":"22","author":"A Human","year":"2019","unstructured":"Human A, Pagnoux C. Diagnosis and management of ADA2 deficient polyarteritis nodosa. Int J Rheum Dis. 2019;22:69\u201377. https:\/\/doi.org\/10.1111\/1756-185X.13283.","journal-title":"Int J Rheum Dis."},{"issue":"1","key":"1555_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/1747493018790064","volume":"14","author":"MT Mackay","year":"2019","unstructured":"Mackay MT, Steinlin M. Recent developments and new frontiers in childhood arterial ischemic stroke. Int J Stroke. 2019;14(1):32\u201343. https:\/\/doi.org\/10.1177\/1747493018790064.","journal-title":"Int J Stroke."},{"issue":"12","key":"1555_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11926-018-0788-3","volume":"20","author":"M Alghamdi","year":"2018","unstructured":"Alghamdi M. Autoinflammatory disease-associated vasculitis\/vasculopathy. Curr Rheumatol Rep. 2018;20(12):87. https:\/\/doi.org\/10.1007\/s11926-018-0788-3.","journal-title":"Curr Rheumatol Rep."},{"issue":"1","key":"1555_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.berh.2018.09.007","volume":"32","author":"S \u00d6zen","year":"2018","unstructured":"\u00d6zen S, S\u00f6nmez HE, Demir S. Pediatric forms of vasculitis. Best Pract Res Clin Rheumatol. 2018;32(1):137\u201347. https:\/\/doi.org\/10.1016\/j.berh.2018.09.007.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"12","key":"1555_CR55","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00467-018-4155-4","volume":"34","author":"S Ozen","year":"2019","unstructured":"Ozen S. What\u2019s new in autoinflammation? Pediatr Nephrol. 2019;34(12):2449\u201356. https:\/\/doi.org\/10.1007\/s00467-018-4155-4.","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"1555_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12722","volume":"287","author":"L Moens","year":"2019","unstructured":"Moens L, Hershfield M, Arts K, Aksentijevich I, Meyts I. Human adenosine deaminase 2 deficiency: a multi-faceted inborn error of immunity. Immunol Rev. 2019;287(1):62\u201372. https:\/\/doi.org\/10.1111\/imr.12722.","journal-title":"Immunol Rev."},{"issue":"10","key":"1555_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-019-0854-5","volume":"21","author":"H Leavis","year":"2019","unstructured":"Leavis H, Zwerina J, Manger B, Fritsch-Stork RDE. Novel developments in primary immunodeficiencies (PID)\u2014a rheumatological perspective. Curr Rheumatol Rep. 2019;21(10):55. https:\/\/doi.org\/10.1007\/s11926-019-0854-5.","journal-title":"Curr Rheumatol Rep."},{"issue":"1","key":"1555_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/BOR.0000000000000669","volume":"32","author":"S Sahin","year":"2020","unstructured":"Sahin S, Adrovic A, Kasapcopur O. A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2. Curr Opin Rheumatol. 2020;32(1):3\u201314. https:\/\/doi.org\/10.1097\/BOR.0000000000000669.","journal-title":"Curr Opin Rheumatol."},{"issue":"4","key":"1555_CR59","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41390-019-0614-2","volume":"87","author":"HE S\u00f6nmez","year":"2020","unstructured":"S\u00f6nmez HE, Karaaslan C, de Jesus AA, et al. A clinical score to guide in decision making for monogenic type I IFNopathies. Pediatr Res. 2020;87(4):745\u201352. https:\/\/doi.org\/10.1038\/s41390-019-0614-2.","journal-title":"Pediatr Res."},{"issue":"3","key":"1555_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00247-019-04536-9","volume":"50","author":"M Navallas","year":"2020","unstructured":"Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Zaki FM, Navarro OM. Autoinflammatory diseases in childhood, part 1: monogenic syndromes. Pediatr Radiol. 2020;50(3):415\u201330. https:\/\/doi.org\/10.1007\/s00247-019-04536-9.","journal-title":"Pediatr Radiol."},{"key":"1555_CR61","doi-asserted-by":"publisher","first-page":"108381","DOI":"10.1016\/j.clim.2020.108381","volume":"214","author":"CE Pain","year":"2020","unstructured":"Pain CE. Juvenile-onset Beh\u00e7et\u2019s syndrome and mimics. Clin Immunol. 2020;214:108381. https:\/\/doi.org\/10.1016\/j.clim.2020.108381.","journal-title":"Clin Immunol."},{"key":"1555_CR62","doi-asserted-by":"publisher","first-page":"108411","DOI":"10.1016\/j.clim.2020.108411","volume":"215","author":"Z Huang","year":"2020","unstructured":"Huang Z, Li T, Nigrovic PA, Lee PY. Polyarteritis nodosa and deficiency of adenosine deaminase 2 \u2013 shared genealogy, generations apart. Clin Immunol. 2020;215:108411. https:\/\/doi.org\/10.1016\/j.clim.2020.108411.","journal-title":"Clin Immunol"},{"issue":"7","key":"1555_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-020-00908-5","volume":"22","author":"E Sag","year":"2020","unstructured":"Sag E, Demir S, Ozen S. Clusters in pediatric rheumatic diseases. Curr Rheumatol Rep. 2020;22(7):28. https:\/\/doi.org\/10.1007\/s11926-020-00908-5.","journal-title":"Curr Rheumatol Rep."},{"issue":"Supplement_3","key":"1555_CR64","doi-asserted-by":"publisher","first-page":"iii95","DOI":"10.1093\/rheumatology\/kez599","volume":"59","author":"S Ozen","year":"2020","unstructured":"Ozen S, Sag E. Childhood vasculitis. Rheumatology. 2020;59(Supplement_3):iii95\u2013iii100. https:\/\/doi.org\/10.1093\/rheumatology\/kez599.","journal-title":"Rheumatology."},{"issue":"2","key":"1555_CR65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00467-017-3597-4","volume":"33","author":"P Brogan","year":"2018","unstructured":"Brogan P, Eleftheriou D. Vasculitis update: pathogenesis and biomarkers. Pediatr Nephrol. 2018;33(2):187\u201398. https:\/\/doi.org\/10.1007\/s00467-017-3597-4.","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"1555_CR66","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.berh.2017.12.001","volume":"31","author":"HJ Lachmann","year":"2017","unstructured":"Lachmann HJ. Periodic fever syndromes. Best Pract Res Clin Rheumatol. 2017;31(4):596\u2013609. https:\/\/doi.org\/10.1016\/j.berh.2017.12.001.","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"1555_CR67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fped.2018.00377","volume":"6","author":"S Demir","year":"2018","unstructured":"Demir S, Sag E, Dedeoglu F, Ozen S. Vasculitis in systemic autoinflammatory diseases. Front Pediatr. 2018;6:377. https:\/\/doi.org\/10.3389\/fped.2018.00377.","journal-title":"Front Pediatr."},{"key":"1555_CR68","unstructured":"Aksentijevich I, Sampaio Moura N, Barron K. Adenosine deaminase 2 deficiency. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews\u00ae. Seattle: University of Washington; 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544951\/. Accessed 11 Jan 2023."},{"key":"1555_CR69","unstructured":"Karadag O, Jayne DJ. Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda. Clin Exp Rheumatol. 2018;36 Suppl 111(2):135-142."},{"issue":"1","key":"1555_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","volume":"13","author":"AM Flinn","year":"2018","unstructured":"Flinn AM, Gennery AR. Adenosine deaminase deficiency: a review. Orphanet J Rare Dis. 2018;13(1):65. https:\/\/doi.org\/10.1186\/s13023-018-0807-5.","journal-title":"Orphanet J Rare Dis."},{"issue":"10","key":"1555_CR71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11926-020-00944-1","volume":"22","author":"JL Kendall","year":"2020","unstructured":"Kendall JL, Springer JM. The many faces of a monogenic autoinflammatory disease: adenosine deaminase 2 deficiency. Curr Rheumatol Rep. 2020;22(10):64. https:\/\/doi.org\/10.1007\/s11926-020-00944-1.","journal-title":"Curr Rheumatol Rep."},{"key":"1555_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00325481.2022.2088940","volume":"22","author":"JM Springer","year":"2022","unstructured":"Springer JM, Byram K. Polyarteritis nodosa: an evolving primary systemic vasculitis. Postgrad Med. Published online June. 2022;22:1\u20138. https:\/\/doi.org\/10.1080\/00325481.2022.2088940.","journal-title":"Postgrad Med"},{"key":"1555_CR73","doi-asserted-by":"publisher","first-page":"869570","DOI":"10.3389\/fimmu.2022.869570","volume":"13","author":"RK Pilania","year":"2022","unstructured":"Pilania RK, Banday AZ, Sharma S, et al. Deficiency of human adenosine deaminase type 2 \u2013 a diagnostic conundrum for the hematologist. Front Immunol. 2022;13:869570. https:\/\/doi.org\/10.3389\/fimmu.2022.869570.","journal-title":"Front Immunol."},{"issue":"3","key":"1555_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00281-022-00918-8","volume":"44","author":"PY Lee","year":"2022","unstructured":"Lee PY, Aksentijevich I, Zhou Q. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2). Semin Immunopathol. 2022;44(3):269\u201380. https:\/\/doi.org\/10.1007\/s00281-022-00918-8.","journal-title":"Semin Immunopathol."},{"issue":"2","key":"1555_CR75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/MOP.0000000000001106","volume":"34","author":"Y Bilginer","year":"2022","unstructured":"Bilginer Y, Ozen S. Polyarteritis nodosa. Curr Opin Pediatr. 2022;34(2):229\u201333. https:\/\/doi.org\/10.1097\/MOP.0000000000001106.","journal-title":"Curr Opin Pediatr."},{"issue":"1","key":"1555_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgme.2021.12.014","volume":"135","author":"M Mastrangelo","year":"2022","unstructured":"Mastrangelo M, Ricciardi G, Giordo L, Michele MD, Toni D, Leuzzi V. Stroke and stroke-like episodes in inborn errors of metabolism: pathophysiological and clinical implications. Mol Genet Metab. 2022;135(1):3\u201314. https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.014.","journal-title":"Mol Genet Metab."},{"issue":"11","key":"1555_CR77","doi-asserted-by":"publisher","first-page":"102944","DOI":"10.1016\/j.autrev.2021.102944","volume":"20","author":"I Maccora","year":"2021","unstructured":"Maccora I, Marrani E, Mastrolia MV, et al. Ocular involvement in monogenic autoinflammatory disease. Autoimmun Rev. 2021;20(11):102944. https:\/\/doi.org\/10.1016\/j.autrev.2021.102944.","journal-title":"Autoimmun Rev."},{"issue":"1","key":"1555_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18176\/jiaci.0748","volume":"32","author":"B Zhang","year":"2022","unstructured":"Zhang B, Xu N, Chen J, et al. Treatment and outcome in deficiency of adenosine deaminase 2: a literature review. J Investig Allergy Clin Immunol. 2022;32(1):13\u201322. https:\/\/doi.org\/10.18176\/jiaci.0748.","journal-title":"J Investig Allergy Clin Immunol."},{"key":"1555_CR79","doi-asserted-by":"publisher","first-page":"671755","DOI":"10.3389\/fimmu.2021.671755","volume":"12","author":"M L\u00f3pez-Nevado","year":"2021","unstructured":"L\u00f3pez-Nevado M, Gonz\u00e1lez-Granado LI, Ruiz-Garc\u00eda R, et al. Primary immune regulatory disorders with an autoimmune lymphoproliferative syndrome-like phenotype: immunologic evaluation, early diagnosis and management. Front Immunol. 2021;12:671755. https:\/\/doi.org\/10.3389\/fimmu.2021.671755.","journal-title":"Front Immunol."},{"issue":"4","key":"1555_CR80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1590\/0004-282x-anp-2020-0105","volume":"79","author":"R Pizzatto","year":"2021","unstructured":"Pizzatto R, Resende LL, Lobo CFT, et al. Arteriopathy in pediatric stroke: an underestimated clinical entity. Arq Neuropsiquiatr. 2021;79(4):321\u201333. https:\/\/doi.org\/10.1590\/0004-282x-anp-2020-0105.","journal-title":"Arq Neuropsiquiatr."},{"issue":"10","key":"1555_CR81","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1007\/s10067-021-05711-w","volume":"40","author":"B Pinto","year":"2021","unstructured":"Pinto B, Deo P, Sharma S, Syal A, Sharma A. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment. Clin Rheumatol. 2021;40(10):3883\u201396. https:\/\/doi.org\/10.1007\/s10067-021-05711-w.","journal-title":"Clin Rheumatol."},{"issue":"4","key":"1555_CR82","doi-asserted-by":"publisher","first-page":"102784","DOI":"10.1016\/j.autrev.2021.102784","volume":"20","author":"E Conticini","year":"2021","unstructured":"Conticini E, Sota J, Falsetti P, et al. Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review. Autoimmun Rev. 2021;20(4):102784. https:\/\/doi.org\/10.1016\/j.autrev.2021.102784.","journal-title":"Autoimmun Rev."},{"issue":"2","key":"1555_CR83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/acr2.11189","volume":"3","author":"YC Lin","year":"2021","unstructured":"Lin YC, Kalot MA, Husainat NM, et al. Polyarteritis nodosa: a systematic review of test accuracy and benefits and harms of common treatments. ACR Open Rheumatol. 2021;3(2):91\u2013100. https:\/\/doi.org\/10.1002\/acr2.11189.","journal-title":"ACR Open Rheumatol."},{"issue":"3","key":"1555_CR84","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","volume":"74","author":"Y Kaljas","year":"2017","unstructured":"Kaljas Y, Liu C, Skaldin M, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci. 2017;74(3):555\u201370. https:\/\/doi.org\/10.1007\/s00018-016-2357-0.","journal-title":"Cell Mol Life Sci."},{"issue":"12","key":"1555_CR85","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrrheum.2017.175","volume":"13","author":"J Collison","year":"2017","unstructured":"Collison J. Stem cell transplantation for DADA2. Nat Rev Rheumatol. 2017;13(12):694. https:\/\/doi.org\/10.1038\/nrrheum.2017.175.","journal-title":"Nat Rev Rheumatol."},{"issue":"2","key":"1555_CR86","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1212\/CON.0000000000000833","volume":"26","author":"J Putaala","year":"2020","unstructured":"Putaala J. Ischemic stroke in young adults. Contin Lifelong Learn Neurol. 2020;26(2):386\u2013414. https:\/\/doi.org\/10.1212\/CON.0000000000000833.","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"1","key":"1555_CR87","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1573397114666180726093731","volume":"15","author":"S Demir","year":"2018","unstructured":"Demir S, S\u00f6nmez HE, \u00d6zen S. Vasculitis: decade in review. Curr Rheumatol Rev. 2018;15(1):14\u201322. https:\/\/doi.org\/10.2174\/1573397114666180726093731.","journal-title":"Curr Rheumatol Rev."},{"issue":"8","key":"1555_CR88","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-017-0449-8","volume":"37","author":"G Bucciol","year":"2017","unstructured":"Bucciol G, Delafontaine S, Segers H, et al. Hematopoietic stem cell transplantation in ADA2 deficiency: early restoration of ADA2 enzyme activity and disease relapse upon drop of donor chimerism. J Clin Immunol. 2017;37(8):746\u201350. https:\/\/doi.org\/10.1007\/s10875-017-0449-8.","journal-title":"J Clin Immunol."},{"issue":"24","key":"1555_CR89","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1182\/blood-2017-10-811125","volume":"130","author":"KM Debatin","year":"2017","unstructured":"Debatin KM. HSCT cures ADA2 deficiency. Blood. 2017;130(24):2582\u20133. https:\/\/doi.org\/10.1182\/blood-2017-10-811125.","journal-title":"Blood."},{"issue":"Suppl 117(2)","key":"1555_CR90","first-page":"52","volume":"37","author":"HE S\u00f6nmez","year":"2019","unstructured":"S\u00f6nmez HE, Arma\u011fan B, Ayan G, et al. Polyarteritis nodosa: lessons from 25 years of experience. Clin Exp Rheumatol. 2019;37(Suppl 117(2)):52\u20136.","journal-title":"Clin Exp Rheumatol."},{"issue":"6","key":"1555_CR91","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ajhg.2018.10.027","volume":"103","author":"JC Ulirsch","year":"2018","unstructured":"Ulirsch JC, Verboon JM, Kazerounian S, et al. The genetic landscape of Diamond-Blackfan anemia. Am J Hum Genet. 2018;103(6):930\u201347. https:\/\/doi.org\/10.1016\/j.ajhg.2018.10.027.","journal-title":"Am J Hum Genet."},{"key":"1555_CR92","doi-asserted-by":"publisher","first-page":"630691","DOI":"10.3389\/fimmu.2021.630691","volume":"12","author":"D Suri","year":"2021","unstructured":"Suri D, Rawat A, Jindal AK, et al. Spectrum of systemic auto-inflammatory diseases in India: a multi-centric experience. Front Immunol. 2021;12:630691. https:\/\/doi.org\/10.3389\/fimmu.2021.630691.","journal-title":"Front Immunol."},{"issue":"11","key":"1555_CR93","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bmt.2017.173","volume":"52","author":"H Hashem","year":"2017","unstructured":"Hashem H, Vatsayan A, Gupta A, Nagle K, Hershfield M, Dalal J. Successful reduced intensity hematopoietic cell transplant in a patient with deficiency of adenosine deaminase 2. Bone Marrow Transplant. 2017;52(11):1575\u20136. https:\/\/doi.org\/10.1038\/bmt.2017.173.","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"1555_CR94","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/1744666X.2022.2078704","volume":"18","author":"S Signa","year":"2022","unstructured":"Signa S, Dell\u2019Orso G, Gattorno M, Faraci M. Hematopoietic stem cell transplantation in systemic autoinflammatory diseases - the first one hundred transplanted patients. Expert Rev Clin Immunol. 2022;18(7):667\u201389. https:\/\/doi.org\/10.1080\/1744666X.2022.2078704.","journal-title":"Expert Rev Clin Immunol."},{"key":"1555_CR95","doi-asserted-by":"publisher","unstructured":"Mandviwala MM, Verbsky JW, Khammar AJ, Walsh RD. Internuclear ophthalmoplegia in a child with deficiency of adenosine deaminase 2. J Neuroophthalmol. 2021;Publish Ahead of Print; https:\/\/doi.org\/10.1097\/WNO.0000000000001354.","DOI":"10.1097\/WNO.0000000000001354"},{"key":"1555_CR96","doi-asserted-by":"publisher","first-page":"642454","DOI":"10.3389\/fmed.2021.642454","volume":"8","author":"Y Xu","year":"2021","unstructured":"Xu Y, Shan Y, Hu Y, et al. Case report: An adult patient with deficiency of adenosine deaminase 2 resembled unilateral frosted branch angiitis. Front Med. 2021;8:642454. https:\/\/doi.org\/10.3389\/fmed.2021.642454.","journal-title":"Front Med."},{"issue":"8","key":"1555_CR97","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, et al. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol Hoboken NJ. 2017;69(8):1689\u2013700. https:\/\/doi.org\/10.1002\/art.40147.","journal-title":"Arthritis Rheumatol Hoboken NJ."},{"issue":"2","key":"1555_CR98","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","volume":"38","author":"TF Michniacki","year":"2018","unstructured":"Michniacki TF, Hannibal M, Ross CW, et al. Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure. J Clin Immunol. 2018;38(2):166\u201373. https:\/\/doi.org\/10.1007\/s10875-018-0480-4.","journal-title":"J Clin Immunol."},{"key":"1555_CR99","doi-asserted-by":"publisher","unstructured":"Rama M, Duflos C, Melki I, et al. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet EJHG. 2018;26(7):960-971. :https:\/\/doi.org\/10.1038\/s41431-018-0130-6","DOI":"10.1038\/s41431-018-0130-6"},{"issue":"6","key":"1555_CR100","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.jaad.2020.03.110","volume":"83","author":"F Chasset","year":"2020","unstructured":"Chasset F, Fayand A, Moguelet P, et al. Clinical and pathological dermatological features of deficiency of adenosine deaminase 2: a multicenter, retrospective, observational study. J Am Acad Dermatol. 2020;83(6):1794\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.110.","journal-title":"J Am Acad Dermatol."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01555-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:30:59Z","timestamp":1700458259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01555-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01555-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2974564\/v1","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"28 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publishing"}},{"value":"Isabelle Meyts has received research funding at UZ Leuven from CSL Behring, unrelated to this study. She also participates as an advisory board member for Boehringer-Ingelheim, through LRD KU Leuven. Leuven Research and Development, the technology transfer office of KU Leuven, has received consultancy and speaker\u2019s fees, or research grants on behalf of Rik Lories from Abbvie, Amgen (formerly Celgene), Biosplice Therapeutics (formerly Samumed), Eli-Lilly, Galapagos, Janssen, MSD, Novartis, Pfizer, Sandoz, UCB, and Viatris. This study is supported by the ERN-RITA.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}